VEDICINALS® 9 White Paper The following white paper details the 9 bioactive molecules used in formulating VEDICINALS® 9 including their properties, meta-analysis of past published studies and their specified drug targets and along with the manners that they individually rectify the disruptions in various human host cellular pathways caused by the SARS-CoV-2 coronavirus. (To …
VEDICINALS® 9 Randomized Human Clinical Trial The findings of the retrospective randomized clinical study demonstrate a promising role of VEDICINALS® 9 as an adjuvant to SOC therapy for COVID-19. It was found to help curtailing symptoms, preventing disease progression and strengthening the natural defences of the human host and also was found to aid in …
VEDICINALS® 9 Safety Studies Three different studies were conducted to determine the safety aspects of VEDICINALS® 9 prior to human clinical studies and these studies involved high dose oral ingestion of VEDICINALS® 9 by Sprague Dawley Rats. In the first two which involved acute and sub-acute toxicity testing without single mortality over periods of 14 …
VEDICINALS® 9 & Improvements Of Lung Damage In COVID-19 Patients Although all patients were randomly selected, the patients in the VEDICINALS® 9 treatment group showed at onset of trial a much higher percentage of abnormal lung x-ray findings, probably by coincidence. The observed improvements, when compared to Standard Treatment Group are very remarkable. X-Ray …
VEDICINALS® 9 and Improvements Of Lung Damage In COVID-19 Patients Read More »
Bioactive Molecules In VEDICINALS® 9 Here you find a detailed description of the 9 bioactive molecules used in VEDICINALS® 9 and their documented efficacy against SARS-CoV-2 Coronavirus and Covid19 disease. 1.Baicalin Baicalin is a flavonoid from the root of Scutellaria Baicalensis Corsi with known anti-inflammatory, anti-allergic, antibacterial, antihypertensive effects. Baicalin has attracted increasing scientific attention …
Computational Analysis on The Drug Target Pathways Parallel to all ongoing trials and formulation development, our scientific in silico teams we’re conducting close to 400 individual molecular docking analysis on all described drug target pathways. Please see below chart with all the detailed docking scores of our bio active molecules and the subsequent virus/host cell …
Computational Analysis And Vedicinals® 9 Efficacy Against Mutants Read More »
VEDICINALS® 9 White Paper The following white paper details the 9 bioactive molecules used in formulating VEDICINALS® 9 including their properties, meta-analysis of past published studies and their specified drug targets and along with the manners that they individually rectify the disruptions in various human host cellular pathways caused by the SARS-CoV-2 coronavirus. (To …
VEDICINALS® 9 Randomized Human Clinical Trial The findings of the retrospective randomized clinical study demonstrate a promising role of VEDICINALS® 9 as an adjuvant to SOC therapy for COVID-19. It was found to help curtailing symptoms, preventing disease progression and strengthening the natural defences of the human host and also was found to aid in …
VEDICINALS® 9 Safety Studies Three different studies were conducted to determine the safety aspects of VEDICINALS® 9 prior to human clinical studies and these studies involved high dose oral ingestion of VEDICINALS® 9 by Sprague Dawley Rats. In the first two which involved acute and sub-acute toxicity testing without single mortality over periods of 14 …
VEDICINALS® 9 & Improvements Of Lung Damage In COVID-19 Patients Although all patients were randomly selected, the patients in the VEDICINALS® 9 treatment group showed at onset of trial a much higher percentage of abnormal lung x-ray findings, probably by coincidence. The observed improvements, when compared to Standard Treatment Group are very remarkable. X-Ray …
VEDICINALS® 9 and Improvements Of Lung Damage In COVID-19 Patients Read More »
